Davenport & Co’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
2,731
-80
-3% -$44.9K 0.01% 654
2026
Q1
$1.58M Sell
2,811
-522
-16% -$335K 0.01% 582
2025
Q4
$2.25M Sell
3,333
-1,857
-36% -$1.26M 0.01% 506
2025
Q3
$3.32M Sell
5,190
-1,159
-18% -$703K 0.02% 424
2025
Q2
$3.41M Sell
6,349
-444
-7% -$212K 0.02% 402
2025
Q1
$2.85M Buy
6,793
+1,140
+20% +$495K 0.02% 412
2024
Q4
$2.34M Buy
5,653
+1,321
+30% +$579K 0.01% 444
2024
Q3
$2.19M Sell
4,332
-165
-4% -$80.2K 0.01% 456
2024
Q2
$2.19M Buy
4,497
+8
+0.2% +$4.02K 0.01% 436
2024
Q1
$2.42M Sell
4,489
-152
-3% -$83.1K 0.01% 403
2023
Q4
$2.58M Sell
4,641
-567
-11% -$266K 0.02% 370
2023
Q3
$2.28M Sell
5,208
-169
-3% -$84.3K 0.02% 361
2023
Q2
$2.7M Sell
5,377
-913
-15% -$438K 0.02% 344
2023
Q1
$3.15M Buy
6,290
+130
+2% +$62.2K 0.02% 320
2022
Q4
$2.51M Sell
6,160
-303
-5% -$118K 0.02% 339
2022
Q3
$2.11M Buy
6,463
+277
+4% +$102K 0.02% 345
2022
Q2
$2.17M Sell
6,186
-366
-6% -$149K 0.02% 352
2022
Q1
$3.58M Buy
6,552
+678
+12% +$357K 0.02% 303
2021
Q4
$3.87M Buy
5,874
+3,518
+149% +$2.21M 0.03% 299
2021
Q3
$1.47M Buy
2,356
+1,276
+118% +$857K 0.01% 460
2021
Q2
$682K Buy
+1,080
New +$596K 0.01% 565

Other funds holding IDXX

Davenport & Co's IDXX Position: Q2 2026 in Review

Davenport & Co reduced its Idexx Laboratories (IDXX) stake by 2.8% in Q2 2026, selling an estimated $44.9K and leaving 2,731 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #654.

Davenport & Co first reported a position in IDXX in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.87M in Q4 2021. 265 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Davenport & Co held 2,731 shares of Idexx Laboratories worth $1.44M as of Q2 2026.
  • Davenport & Co sold 80 Idexx Laboratories shares in Q2 2026, an estimated $44.9K.
  • Idexx Laboratories made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #654 holding.
  • Davenport & Co first reported a position in Idexx Laboratories in Q2 2021 and has held it in 21 quarters since.
  • Davenport & Co's Idexx Laboratories position peaked at $3.87M in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.